Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.

Slični predmeti

• Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
  od: Satoshi Kawano, i dr.
  Izdano: (2016-01-01)
• Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
  od: Sarah K Knutson, i dr.
  Izdano: (2014-01-01)
• EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma
  od: Muhammad Mushtaq, i dr.
  Izdano: (2024-11-01)
• Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
  od: Changchien Yi-Che, i dr.
  Izdano: (2012-10-01)
• Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
  od: Haruka Shinohara, i dr.
  Izdano: (2022-12-01)